US Stock MarketDetailed Quotes

INM InMed Pharmaceuticals

Watchlist
  • 4.5068
  • +0.0868+1.96%
Close Dec 4 16:00 ET
  • 4.6400
  • +0.1332+2.96%
Post 20:02 ET
3.24MMarket Cap-587P/E (TTM)

InMed Pharmaceuticals Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Sep 30, 2024
(FY)Jun 30, 2024
(Q4)Jun 30, 2024
(Q3)Mar 31, 2024
(Q2)Dec 31, 2023
(Q1)Sep 30, 2023
(FY)Jun 30, 2023
(Q4)Jun 30, 2023
(Q3)Mar 31, 2023
(Q2)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
15.98%-1.83M
4.08%-6.99M
-56.42%-1.03M
-16.76%-1.93M
31.88%-1.85M
3.61%-2.17M
53.26%-7.28M
83.74%-657.93K
69.03%-1.66M
23.22%-2.71M
Net income from continuing operations
33.86%-1.68M
3.42%-7.68M
-472.61%-1.94M
13.77%-1.72M
29.65%-1.48M
27.73%-2.54M
57.27%-7.95M
95.70%-338.39K
42.52%-2M
50.94%-2.1M
Operating gains losses
161.15%5.27K
936.52%12.26K
1,110.99%9.66K
5,717.24%1.63K
-65.34%-1.04K
-27.83%2.02K
-90.99%1.18K
-165.50%-955
96.01%-29
-105.65%-629
Depreciation and amortization
-2.94%144.98K
1.43%604.52K
0.59%151.86K
1.02%150.69K
3.56%152.61K
0.58%149.36K
16.45%596K
-2.00%150.97K
-2.71%149.16K
-1.74%147.36K
Other non cash items
3.53%-519
-55.67%-1.25K
105.11%21
-1,069.23%-252
-61.41%-481
-348.33%-538
-100.06%-803
-100.03%-411
--26
---298
Change In working capital
-449.85%-327.64K
34.73%-369.34K
352.62%665.61K
-395.36%-418.82K
16.90%-709.77K
-77.16%93.65K
81.59%-565.82K
80.85%-263.48K
106.39%141.8K
-340.14%-854.16K
-Change in receivables
-27.93%68.14K
57.82%-92.44K
-29.85%-145.16K
286.33%165.19K
-126.09%-207.02K
29.77%94.55K
-447.76%-219.15K
-539.79%-111.79K
-337.79%-88.65K
-14,451.57%-91.56K
-Change in inventory
-93.79%24.25K
-88.29%66.22K
-399.09%-92.78K
-258.38%-449.11K
31.98%217.78K
187.94%390.33K
128.23%565.56K
98.26%-18.59K
165.71%283.58K
132.89%165.02K
-Change in prepaid assets
16.20%328.87K
-93.22%20.28K
174.35%540.94K
-28.42%94.29K
-90.95%-897.96K
-35.76%283.02K
56.92%299.19K
-61.66%197.17K
111.25%131.73K
-320.82%-470.27K
-Change in payables and accrued expense
-14.21%-642.39K
105.61%45.28K
312.82%470.73K
-36.45%-104.34K
169.04%241.38K
-253.19%-562.48K
0.62%-806.53K
64.12%-221.19K
84.44%-76.47K
-145.66%-349.61K
-Change in other current assets
--0
-10.88%4.91K
--0
--0
--1.79K
-43.38%3.12K
108.96%5.51K
--0
--0
--0
-Change in other current liabilities
-7.90%-106.51K
6.83%-397.42K
0.88%-108.12K
11.24%-96.19K
12.76%-94.4K
2.17%-98.71K
-24.78%-426.58K
0.13%-109.09K
-0.81%-108.38K
---108.21K
-Change in other working capital
----
-200.00%-16.17K
--0
---28.66K
5,984.08%28.66K
-203.00%-16.17K
414.49%16.17K
--0
--0
--471
Cash from discontinued investing activities
Operating cash flow
15.98%-1.83M
4.08%-6.99M
-56.42%-1.03M
-16.76%-1.93M
31.88%-1.85M
3.61%-2.17M
53.26%-7.28M
83.74%-657.93K
69.03%-1.66M
23.22%-2.71M
Investing cash flow
Cash flow from continuing investing activities
0
98.60%-9.29K
0
100.00%-2
98.14%-9.29K
0
1.66%-661.8K
95.37%-33.61K
-3,508.16%-128.2K
-263.39%-500K
Net PPE purchase and sale
----
94.26%-9.29K
--0
100.00%-2
----
----
-313.74%-161.8K
---33.61K
-3,508.16%-128.2K
----
Net business purchase and sale
----
--0
--0
--0
----
----
-139.36%-500K
--0
--0
----
Net investment purchase and sale
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cash from discontinued investing activities
Investing cash flow
--0
98.60%-9.29K
--0
100.00%-2
98.14%-9.29K
--0
1.66%-661.8K
95.37%-33.61K
-3,508.16%-128.2K
-263.39%-500K
Financing cash flow
Cash flow from continuing financing activities
838.24K
-56.42%4.65M
176
0
-12.44%4.65M
0
-29.13%10.68M
0
-117.31%-63.7K
735.69%5.32M
Net common stock issuance
--1.03M
-56.42%4.65M
100.15%1
--0
-1.90%4.65M
--0
-37.71%10.68M
-100.01%-646
---63.7K
2,695,346.59%4.74M
Proceeds from stock option exercised by employees
----
-72.91%175
----
----
----
----
--646
----
----
----
Net other financing activities
---191.82K
----
----
----
----
----
----
----
----
----
Cash from discontinued financing activities
Financing cash flow
--838.24K
-56.42%4.65M
--176
--0
-12.44%4.65M
--0
-29.13%10.68M
--0
-117.31%-63.7K
735.69%5.32M
Net cash flow
Beginning cash position
-26.27%6.57M
44.29%8.91M
-20.86%7.6M
-16.74%9.53M
-27.94%6.74M
44.29%8.91M
-16.11%6.18M
62.83%9.6M
1.53%11.45M
-39.06%9.35M
Current changes in cash
54.53%-988.57K
-185.57%-2.34M
-48.80%-1.03M
-4.64%-1.93M
33.04%2.8M
-168.51%-2.17M
330.61%2.74M
-348.26%-691.54K
65.65%-1.85M
151.73%2.1M
End cash Position
-17.14%5.58M
-26.27%6.57M
-26.27%6.57M
-20.86%7.6M
-16.74%9.53M
-27.94%6.74M
44.29%8.91M
44.29%8.91M
62.83%9.6M
1.53%11.45M
Free cash flow
15.98%-1.83M
6.04%-7M
-48.82%-1.03M
-8.38%-1.93M
31.54%-1.86M
3.61%-2.17M
52.35%-7.45M
82.91%-691.54K
66.65%-1.78M
23.99%-2.71M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
(Q1)Sep 30, 2024(FY)Jun 30, 2024(Q4)Jun 30, 2024(Q3)Mar 31, 2024(Q2)Dec 31, 2023(Q1)Sep 30, 2023(FY)Jun 30, 2023(Q4)Jun 30, 2023(Q3)Mar 31, 2023(Q2)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 15.98%-1.83M4.08%-6.99M-56.42%-1.03M-16.76%-1.93M31.88%-1.85M3.61%-2.17M53.26%-7.28M83.74%-657.93K69.03%-1.66M23.22%-2.71M
Net income from continuing operations 33.86%-1.68M3.42%-7.68M-472.61%-1.94M13.77%-1.72M29.65%-1.48M27.73%-2.54M57.27%-7.95M95.70%-338.39K42.52%-2M50.94%-2.1M
Operating gains losses 161.15%5.27K936.52%12.26K1,110.99%9.66K5,717.24%1.63K-65.34%-1.04K-27.83%2.02K-90.99%1.18K-165.50%-95596.01%-29-105.65%-629
Depreciation and amortization -2.94%144.98K1.43%604.52K0.59%151.86K1.02%150.69K3.56%152.61K0.58%149.36K16.45%596K-2.00%150.97K-2.71%149.16K-1.74%147.36K
Other non cash items 3.53%-519-55.67%-1.25K105.11%21-1,069.23%-252-61.41%-481-348.33%-538-100.06%-803-100.03%-411--26---298
Change In working capital -449.85%-327.64K34.73%-369.34K352.62%665.61K-395.36%-418.82K16.90%-709.77K-77.16%93.65K81.59%-565.82K80.85%-263.48K106.39%141.8K-340.14%-854.16K
-Change in receivables -27.93%68.14K57.82%-92.44K-29.85%-145.16K286.33%165.19K-126.09%-207.02K29.77%94.55K-447.76%-219.15K-539.79%-111.79K-337.79%-88.65K-14,451.57%-91.56K
-Change in inventory -93.79%24.25K-88.29%66.22K-399.09%-92.78K-258.38%-449.11K31.98%217.78K187.94%390.33K128.23%565.56K98.26%-18.59K165.71%283.58K132.89%165.02K
-Change in prepaid assets 16.20%328.87K-93.22%20.28K174.35%540.94K-28.42%94.29K-90.95%-897.96K-35.76%283.02K56.92%299.19K-61.66%197.17K111.25%131.73K-320.82%-470.27K
-Change in payables and accrued expense -14.21%-642.39K105.61%45.28K312.82%470.73K-36.45%-104.34K169.04%241.38K-253.19%-562.48K0.62%-806.53K64.12%-221.19K84.44%-76.47K-145.66%-349.61K
-Change in other current assets --0-10.88%4.91K--0--0--1.79K-43.38%3.12K108.96%5.51K--0--0--0
-Change in other current liabilities -7.90%-106.51K6.83%-397.42K0.88%-108.12K11.24%-96.19K12.76%-94.4K2.17%-98.71K-24.78%-426.58K0.13%-109.09K-0.81%-108.38K---108.21K
-Change in other working capital -----200.00%-16.17K--0---28.66K5,984.08%28.66K-203.00%-16.17K414.49%16.17K--0--0--471
Cash from discontinued investing activities
Operating cash flow 15.98%-1.83M4.08%-6.99M-56.42%-1.03M-16.76%-1.93M31.88%-1.85M3.61%-2.17M53.26%-7.28M83.74%-657.93K69.03%-1.66M23.22%-2.71M
Investing cash flow
Cash flow from continuing investing activities 098.60%-9.29K0100.00%-298.14%-9.29K01.66%-661.8K95.37%-33.61K-3,508.16%-128.2K-263.39%-500K
Net PPE purchase and sale ----94.26%-9.29K--0100.00%-2---------313.74%-161.8K---33.61K-3,508.16%-128.2K----
Net business purchase and sale ------0--0--0---------139.36%-500K--0--0----
Net investment purchase and sale --0--0--0--0--0--0--0--0--0--0
Cash from discontinued investing activities
Investing cash flow --098.60%-9.29K--0100.00%-298.14%-9.29K--01.66%-661.8K95.37%-33.61K-3,508.16%-128.2K-263.39%-500K
Financing cash flow
Cash flow from continuing financing activities 838.24K-56.42%4.65M1760-12.44%4.65M0-29.13%10.68M0-117.31%-63.7K735.69%5.32M
Net common stock issuance --1.03M-56.42%4.65M100.15%1--0-1.90%4.65M--0-37.71%10.68M-100.01%-646---63.7K2,695,346.59%4.74M
Proceeds from stock option exercised by employees -----72.91%175------------------646------------
Net other financing activities ---191.82K------------------------------------
Cash from discontinued financing activities
Financing cash flow --838.24K-56.42%4.65M--176--0-12.44%4.65M--0-29.13%10.68M--0-117.31%-63.7K735.69%5.32M
Net cash flow
Beginning cash position -26.27%6.57M44.29%8.91M-20.86%7.6M-16.74%9.53M-27.94%6.74M44.29%8.91M-16.11%6.18M62.83%9.6M1.53%11.45M-39.06%9.35M
Current changes in cash 54.53%-988.57K-185.57%-2.34M-48.80%-1.03M-4.64%-1.93M33.04%2.8M-168.51%-2.17M330.61%2.74M-348.26%-691.54K65.65%-1.85M151.73%2.1M
End cash Position -17.14%5.58M-26.27%6.57M-26.27%6.57M-20.86%7.6M-16.74%9.53M-27.94%6.74M44.29%8.91M44.29%8.91M62.83%9.6M1.53%11.45M
Free cash flow 15.98%-1.83M6.04%-7M-48.82%-1.03M-8.38%-1.93M31.54%-1.86M3.61%-2.17M52.35%-7.45M82.91%-691.54K66.65%-1.78M23.99%-2.71M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data